期刊文献+

MR扩散加权成像在甲状腺疾病诊断中的应用 被引量:19

Application of diffusion-weighted MR imaging in the diagnosis of thyroid disease
原文传递
导出
摘要 目的分析和总结MRDWI扫描试验在甲状腺良、恶性疾病中的表现特征。方法术前经MRI常规检查和DWI检查的甲状腺占位病变患者42例,男10例,女32例。年龄20-72岁,平均(42±13)岁,均经手术病理证实。利用美国GE公司图像后处理软件Functool,根据不同的b值(300、500、800s/mm^2)产生ADC值,比较良、恶性病变部位的ADC值,对其进行独立样本的t检验并绘制ROC曲线,分析试验的诊断效能。结果42例甲状腺占位病变样本中,病理诊断为良性的28例,包括甲状腺腺瘤20例、结节性甲状腺肿6例、桥本甲状腺炎2例;恶性肿瘤14例,包括甲状腺乳头状癌11例、滤泡样甲状腺癌2例、不典型增生1例。b值为300s/mm。时,甲状腺良性病变的ADC值为(2.39±0.38)×10^-3mm^2/s,恶性病变的ADC值为(1.60±0.56)×10^-3mm^2/s,差异有统计学意义(t=5.35,P〈0.05)。b值为500s/mm^2时,良性病变的ADC值为(1.85±0.33)×10^-3mm^2/s,恶性病变的ADC值为(1.65±0.42)×10^-3mm^2/s,差异没有统计学意义(t=1.70,P〉0.05)。b值为800s/mm^2时,良性病变的ADC值为(1.61±0.30)×10^-3mm^2/s,恶性病变的ADC值为(1.44±0.29)×10^-3mm^2/s,差异没有统计学意义(t=1.76,P〉0.05)。ROC曲线分析结果:b值为300s/mm^2时,以1.98×10^-3mm^2/s作为甲状腺良、恶性病变ADC值的临界值,灵敏度为85.7%,特异度为78.6%。结论b值为300s/mm^2时,DWI图像质量好,甲状腺良性病变的ADC值明显高于恶性病变的ADC值。 Objective To analyze and summarize the characteristics of thyroid diseases on the MR diffusion-weighted imaging. Methods Forty-two patients with thyroid lesions, including 10 males and 32 females [ age range 20-72 years, mean age (42 ± 13 ) years ] underwent MR DWI before surgery and biopsy. The diagnoses of thyroid lesions were confirmed by pathological results. ADC values of benign and malignant nodules, with different b values (b values was 300,500 and 800 s/mm^3) , were generated by using post-processing software Functool of GE company(USA). The independent-samples t test was used and ROC curve was made to evaluate the diagnostic efficiency of the ADC values by using statistical software SPSS 12. 0. Results Histologically, there were 28 benign lesions and 14 malignant lesions. Benign lesions included 20 cases of thyroid adenoma, 6 cases of nodular goiter and 2 cases of Hashimoto's thyroiditis respectively. Malignant lesions consisted of 11 cases of thyroid papillary carcinoma, 2 cases of follicular thyroid cancer, and 1 case of dysplasia, mean ADC value of benign thyroid lesions was (2. 39 ± 0. 38) × 10^-3 mm^2/s and mean ADC value of malignant thyroid lesions was (1.60 ± 0. 56)×10^-3mm^2/s with b value of 300 s/mm^2. The statistical difference was significant between them ( t = 5.35, P 〈 0. 05 ). The statistical difference of mean ADC values , between benign and malignant nodules with b value of 500 s/mm^2 [ ( 1.85 ±0.33) × 10^-3mm^2/s and (1.65 ±0.42) × 10^-3mm^2/s ], was insignificant (t = 1.70,P〉0.05). Thestatistical difference of mean ADC values, between benign and malignant nodules with b value of 800 s/mm^2 [ ( 1.61± 0. 30) ×10 ^-3 mm^2/s and ( 1.44 ± 0. 29) ×10^-3 mm^2/s ], was insignificant (t = 1.76,P 〉 0. 05). ROC curve indicated that the ADC value of 1.98 ×10^-3 mm^2/s or higher was the cut-off value for differentiating benign from malignant cold thyroid nodules, with a sensitivity of 85.7% , and a specificity of 78.6%. Conclusions The image quality is best with b value of 300 s/mm^2. Mean ADC value of benign lesions was significantly higher than mean ADC value of malignant lesions with b value of 300 s/mm^2.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2012年第6期500-504,共5页 Chinese Journal of Radiology
基金 上海市教委科研创新项目(12ZZ028) 上海市科委重点课题资助项目(09411950700)
关键词 甲状腺疾病 磁共振成像 弥散 Thyroid disease Diffusion magnetic resonance imaging
  • 相关文献

参考文献19

  • 1Mazzaferri EL, Harmer C, Mallick UK, et al. An overview of the management of thyroid cancer. In : Practical management of thyroid cancer: a multidisciplinary approach. London : Springer, 2006 : 1 - 28.
  • 2Wang J, Takashima S, Takayama F, et al. Head and neck lesions: characterization with diffusion-weighted echo-planar MRimaging. Radiology, 2001,220 : 621-630.
  • 3Eida S, Sumi M, Sakihama N, et al. Apparent diffusion coefficient mapping of salivary gland tumors: prediction of the benignancy and malignancy. AJNR Am J Neuroradiol,2007,28 : 116-121.
  • 4King AD, Ahuja AT, Yeung DK, et al. Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. Radiology, 2007,245 : 806-813.
  • 5Tezuka M,Murata Y,Ishida R, et al. MR imaging of the thyroid: correlation between apparent diffusion coefficient and thyroid gland scintigraphy. J Magn Reson Imaging,2003,17:163-169.
  • 6Wang J, Takashima S, Takayama F, et al. Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology ,2001,220:621-630.
  • 7Abdel Razek AA, Soliman NY, Elkhamary S, et al. Role of diffhsion-weighted MR imaging in cervical lymphadenopathy. Eur Radio1,2006,16 : 1468-1477.
  • 8戈明媚,王秋良,刘志钦,刘晓林,廖玉珍,孙玮,孙楠,张英魁.MR螺旋桨扫描技术在消除伪影方面的临床应用[J].中华放射学杂志,2006,40(2):208-212. 被引量:37
  • 9Murtz P, Krautmacher C, Traber F, et al. Diffusion-weighted whole- body MR imaging with background body signal suppression: a feasibilitystudy at 3.0 Tesla. Eur Radiol,2007 ,17 :3031-3037.
  • 10Hayashida Y, Yakushiji T, Awai K, et al. Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results. Eur Radiol, 2006,16:2637-2643.

二级参考文献36

  • 1赵斌,蔡世峰,高佩虹,彭洪娟.MR扩散加权成像鉴别乳腺良恶性病变的研究[J].中华放射学杂志,2005,39(5):497-500. 被引量:146
  • 2沈艳,李明华,姚伟武.磁共振成像新技术在脊柱病变中的应用[J].中国医学影像技术,2005,21(7):1137-1139. 被引量:3
  • 3张晓鹏.在宏观静止中感受微观运动:磁共振扩散加权成像临床应用的若干认识[J].中国医学影像技术,2005,21(12):1796-1798. 被引量:27
  • 4Sotak CH. Nuclear magnetic resonance (NMR) measurement of the apparent diffusion coefficient (ADC) of tissue water and its relationship to cell volume changes in pathological states. Neurochem Int, 2004,45(4):569-582.
  • 5Yeung DK, Wong SY, Griffith JF, et al. Bone marrow diffusion in-osteoporosis: evaluation with quantitative MR diffusion imaging. J Magn Reson Imaging, 2004,19(2) :222-228.
  • 6Raya JG, Dietrich O, Reiser MF, et al. Techniques for diffusion- weighted imaging of bone marrow. Eur J Radiol, 2005,55 (1) : 64- 73.
  • 7Eastwood JD, Vollmer RT, Provenzale JM. Diffusion-weighted imaging in a patient with vertebral and epidural abscesses. AJNR Am J Neuroradiol, 2002,23(3) : 496-498.
  • 8Bammer R, Herneth AM, Maier SE, et al. Line scan diffusion imaging of the spine. AJNR Am J Neuroradiol, 2003,24(1):5-12.
  • 9Mulkern RV, Schwartz RB. In re-characterization of benign and metastatic vertebral compression fractures with quantitative diffusion MR imaging. AJNR Am J Neuroradiol, 2003,24 (7) : 1489- 90.
  • 10Chan JH, Ped WC, Tsui EY, et al. Acute vertebra body compression fractures:discrimination between benign and malignant causes using apparent diffusion coefficients. Br J Radiol, 2002,75(891): 207-214.

共引文献59

同被引文献159

  • 1王明坤,张宝鑫.CT与MRI在诊断甲状腺肿瘤方面的临床价值分析[J].当代医药论丛,2014,12(6):66-67. 被引量:2
  • 2戈明媚,王秋良,刘志钦,刘晓林,廖玉珍,孙玮,孙楠,张英魁.MR螺旋桨扫描技术在消除伪影方面的临床应用[J].中华放射学杂志,2006,40(2):208-212. 被引量:37
  • 3牛丽娟,郝玉芝,周纯武.超声诊断甲状腺占位性病变的价值[J].中华耳鼻咽喉头颈外科杂志,2006,41(6):415-418. 被引量:117
  • 4顾雅佳,冯晓源,唐峰,彭卫军,毛健,杨文涛.乳腺肿瘤的MRI扩散特征及参数选定[J].中华放射学杂志,2007,41(5):451-456. 被引量:45
  • 5杜牧,徐坚民,龚静山,张景忠,朱进,王晓枚.头颈部病变MR扩散成像的初步研究[J].中华放射学杂志,2007,41(9):912-917. 被引量:19
  • 6Koranda P, Halenka M,Myslivecek M, et al. Localization ofparatkyroid enlargement ; dual-tracer subtraction technique anddouble-phase "mTc-MIBI scintigraphy are complementaryprocedures. Eur J Nucl Med Mol Imaging,2008 ,35 :219-220.
  • 7Marcocci C, Cetani F. Clinical practice. Primaryhyperparathyroidism. N Engl J Med,2011,365 -.2389-2397.
  • 8Pallan S,Rahman MO,Khan AA. Diagnosis and management ofprimary hyperparathyroidism. BMJ,2012 ,344 :el013.
  • 9Akbaba G,Berker D,Isik S,et al. A comparative study ofpreoperative imaging methods in patients with primaryhyperparathyroidism : ultrasonography, 99mTc sestamibi ^ singlephoton emission computed tomography, and magnetic resonanceimaging. J Endocrinol Invest ,2012,35 :359-364.
  • 10Leupe PK, Delaere PR, Vander Poorten VL,et al. Pre-operativeimaging in primary hyperparathyroidism with ultrasonography andsestamibi scintigraphy. B-ENT,2011,7:173-180.

引证文献19

二级引证文献191

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部